title: Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline.
authors.affiliation: Institute of Metabolic Science, Wolfson Diabetes and Endocrine Clinic, Addenbrooke's Hospital, Cambridge University NHS Trust, Cambridge, UK.
authors.forename: S
authors.initials: S
authors.lastname: Dash
authors.forename: A K
authors.initials: AK
authors.lastname: Annamalai
authors.forename: H L
authors.initials: HL
authors.lastname: Simpson
authors.forename: N
authors.initials: N
authors.lastname: Sarkies
authors.forename: N M
authors.initials: NM
authors.lastname: Antoun
authors.forename: R
authors.initials: R
authors.lastname: Mannion
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077465:Cabergoline; D003937:Diagnosis, Differential; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D015175:Prolactinoma / Q000175:diagnosis / Q000188:drug therapy*; D019292:Skull Base Neoplasms / Q000175:diagnosis*
chemical_list: D000970:Antineoplastic Agents; D004873:Ergolines; D000077465:Cabergoline